川芎嗪联合氨基胍对糖尿病大鼠肾脏血管内皮细胞生长因子表达的影响

doi:10.3736/jcim20040115

Abstract

Objective: To investigate the therapeutic mechanism of tetromethylpyrazine and aminoguanidine on diabetic nephropathy. Methods: Diabetic rats were induced by streptozotocin. They were divided into 5 groups: normal control group (group C), untreated diabetic group (group DM), tetromethylpyrazine treated group (group TMP), aminoguanidine treated group (group AG) and tetromethylpyrazine and aminoguanidine treated group (group TMP+AG). The expression of vascular endothelial growth factor (VEGF) in renal cortex of the rats in each group was observed by immunohistochemical staining after 12 weeks. Results: The expression of VEGF in renal cortex of the rats in group TMP+AG and group C was alike. The expression of VEGF in renal cortex of group TMP and group AG decreased significantly as compared with that of group C, but was still above normal level.Conclusion: The therapeutic mechanism of tetromethylpyrazine and aminoguanidine on diabetic nephropathy may be inhibiting the over-expression of VEGF in kidney of diabetic rats.

Key words: tetromethylpyrazine, aminoguanidine, diabetic nephropathy, vascular endothelial growth factor

CLC Number:

R587.24

Yan Huang, Shao-qiang Chen, Geng Zhang, Rui-hua Chen. Effect of tetromethylpyrazine and aminoguanidine on expression of vascular endothelial growth factor in kidney of diabetic rats. Journal of Chinese Integrative Medicine, 2004, 2(1): 39-41.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jcim20040115

http://www.jcimjournal.com/EN/Y2004/V2/I1/39

trendmd

Figures/Tables 5

Tab 1

Tab 2

Fig.1

Fig.2

Fig.3

References 8

[1]	Duh E, Aiello LP . Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox[J]. Diabetes, 1999,48(10):1899-1906 doi: 10.2337/diabetes.48.10.1899 pmid: 10512352
[2]	Cooper ME, Vranes D, Youssef S , et al. Increased renal expression of vascular endothelial growth factor(VEGF) and its receptor VEGFR-2 in experimental diabetes[J]. Diabetes, 1999,48(11):2229-2239
[3]	张均田 . 现代药理实验方法(第1版)[M]. 北京: 北京医科大学中国协和医科大学联合出版社, 1998,( 第1版):981-993
[4]	马娜, 刘志红 . 血管内皮细胞生长因子及其与肾脏病的关系[J]. 肾脏病与透析肾移植杂志, 1999,8(4):367-370 doi: 10.3969/j.issn.1006-298X.1999.04.020
[5]	戈继业, 张振岭 . 川芎药理作用研究及临床应用新进展[J]. 中国中西医结合杂志, 1994,14(10):638-639
[6]	翁孝刚, 郭永年, 王道直 , 等. 川芎嗪治疗糖尿病慢性并发症[J]. 新乡医学院学报, 1993,10(3):187-190
[7]	叶山东 . 氨基胍的作用机制及其在糖尿病慢性并发症中的应用[J]. 国外医学·生理病理科学与临床分册, 1998,8(2):168-170
[8]	陈瑞华, 陈少强, 陈振斌 , 等. 糖尿病大鼠早期视网膜超微结构改变及药物治疗的效果[J]. 福建医科大学学报, 2001,35(2):119-123 doi: 10.3969/j.issn.1672-4194.2001.02.006

Related Articles 13

[1]	Zhao-lan Liu, Qing Li , Yu-jie Mu , Ying Gao, Jian-ping Liu. Using nested case-control study to appraise the effectiveness of Chinese medicines in the treatment of diabetic nephropathy. Journal of Chinese Integrative Medicine, 2012, 10(9): 991-996.
[2]	Dong-mei Zhang , Ying Qin , Xi-ying Lu , Ai-ming Wu , Ling-qun Zhu , Shuo-ren Wang , Liang-duo Jiang . Effects of tetramethylpyrazine on angiotensin Ⅱ-induced proliferation and type Ⅰ collagen synthesis of rat cardiac fibroblasts. Journal of Chinese Integrative Medicine, 2009, 7(3): 232-236.
[3]	Gui-song Zhu, Jin-song He. Effects of ligustrazine injection on high glucose-induced type Ⅰ collagen, matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expressions in human peritoneal mesothelial cells in vitro. Journal of Chinese Integrative Medicine, 2009, 7(1): 65-69.
[4]	Xue-peng Sun, Nian-song Wang, Qin Xue, Feng Wang. Volatile oil of Magnolia biondii inhibits expressions of P-selectin protein in serum and renal tissue of rats with diabetic nephropathy. Journal of Chinese Integrative Medicine, 2008, 6(5): 524-529.
[5]	Shan Mou, Zhao-hui Ni, Qing-yi Zhang. Expression of c-met in human kidney fibroblasts induced by high glucose in vitro and the regulation of Radix Astragali. Journal of Chinese Integrative Medicine, 2008, 6(5): 482-487.
[6]	Hong-wei Gu, Zhao-hui Ni, Le-yi Gu, Yu-cheng Yan, Hui-li Dai, Ning-li Li, Min-fang Zhang, Jia-qi Qiang. Effects of Astragalus on expression of renal angiopoietin receptor Tie-2 in diabetic rats. Journal of Chinese Integrative Medicine, 2007, 5(5): 536-540.
[7]	Hua-fa Que, Yuan-yin Zhu, Yun-fei Wang, Zhen Zhang, Jie-nan Xu, Jie Xing, Han-jun Tang. Effects of Chinese herbs for replenishing qi and resolving stagnation on hypoxia-inducible factor-1α and vascular endothelial growth factor in granulation tissue of skin ulcers in rats with diabetes. Journal of Chinese Integrative Medicine, 2007, 5(2): 165-169.
[8]	Shang-pu Gao, Lan Huang, Xin-wei Yang. Effects of Huoxue Bushen Mixture on skin blood vessel neogenesis and vascular endothelial growth factor expression in hair follicle of C57BL/6 mice. Journal of Chinese Integrative Medicine, 2007, 5(2): 170-173.
[9]	Ya-zhou Lin, Chun-xuan Xu, Yu-lian Deng, Lin Chen, Hai Huang, Jian Du. Effects of tetramethylpyrazine on fibrosis of atrial tissue and atrial fibrillation in a canine model of congestive heart failure induced by ventricular tachypacing. Journal of Chinese Integrative Medicine, 2006, 4(1): 35-38.
[10]	Wei Deng, Fang Shu, Jing Chen. Treatment of diabetic nephropathy with integrated traditional Chinese and Western medicine: A report of 30 cases. Journal of Chinese Integrative Medicine, 2005, 3(4): 314-315.
[11]	Zhao-hui Fang, Xiao-ping Zhang, Dao-lin Bao, Yi Xu, Le Luo, Jun Zhou. Effects of Shendan Jianyi Capsule on aldose reductase activity of kidney in diabetic rats. Journal of Chinese Integrative Medicine, 2004, 2(2): 126-128.
[12]	Li-qun He, He-xin Cao, Ya-jing Shen. Effect and mechanism of Tangshenning Recipe on micro-albuminuria in rats with early diabetic nephropathy. Journal of Chinese Integrative Medicine, 2003, 1(2): 119-121.
[13]	Xiao-jing Zhou, Jian-xiong Shen, Lan Huang. Study of the mechanism of preventing proteinuria by Yishen Gujing Decoction (YSGJD) in early diabetic nephropathy. Journal of Chinese Integrative Medicine, 2003, 1(1): 39-41.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2]	Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3]	Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4]	SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5]	Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6]	Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7]	Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8]	Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9]	Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10]	Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239

Group	n	Weight （g）			Blood sugar（mmol/L）
Group	n	4th week	8th week	12th week	4th week	8th week	12th week
Group C	10	281±15	301±12	316±11	3.9±1.1	4.2 ±1.5	4.3±0.8
Group DM	10	181±8**	169±11**	158±6**	21.4±2.3**	22.9±1.3**	22.8±1.9**
GroupTMP	10	203±7**^△△	198±9**^△△	193±9**^△△	19.1±1.8**^△△	17.3±1.5**^△△	20.3±2.7**^△△
Group AG	10	212±15**^△△	206±17**^△△	213±7**^△△	16.7±2.1**^△△	15.4±1.5**^△△	13.4±1.9**^△△
Group TMP+AG	10	205±14**^△△	214±13**^△△	219±9**^△△	12.3±1.7**^△△	10.4±1.2**^△△	5.4±1.5**^△△

Group	n	HbA1c（%）	24 h urinary protein （mg·24h-1）	Ccr（ml·min-1·kg-1）	Kidney weight/Body weight (×10-3)
Group C	10	0.760±0.540	4.25±0.57	3.25±0.41	6.89±0.53
Group DM	10	3.932±1.044**	28.68±1.89**	6.67±1.56**	15.28±1.47**
Group TMP	10	1.745±1.170**^△△	15.99±1.34**^△△	5.49±0.67**^△△	10.46±0.84**^△△
Group AG	10	1.840±0.941**^△△	13.15±0.76**^△△	4.82±0.71**^△△	9.33±1.05**^△△
Group TMP+AG	10	0.856±0.832**^△△	10.21±1.22**^△△	4.43±0.58**^△△	8.25±0.46**^△△

Effect of tetromethylpyrazine and aminoguanidine on expression of vascular endothelial growth factor in kidney of diabetic rats

RichHTML

PDF (PC)

Like